Page 3 - PaxGenBio Co., Ltd.
P. 3
COMPANY INTRODUCTION
• Company Name PaxGenBio Co., Ltd.
• CEO Young Suk Park • Date of Establishment May 1, 2015
Development and Sales in Convergence
• Business field
Technology of Molecular/Immune Diagnostic Product
• Business Conditions Manufacture and Wholesale of Bio Products
• Address #803~807, 361, Simin-daero, Dongan-gu, Anyang-si, Gyeonggi-do, 14057, Republic of Korea
• Tel +82-31-244-5036 • Fax +82-31-244-5037
• Email info@paxgenbio.com • Homepage www.paxgenbio.com
Company History
03 • Designation of Excellent Company for overseas public procurement market
2021
02 • CE-IVD (PaxView ® SARS-CoV-2 MPCR-ULFA Kit)
• Designation of Promising Expert Small and Medium Enterprise by MSS
12
• Designation of Brand K (COVID-19 Diagnostic Kit)
2020
®
03 • CE-IVD (PaxView COVID-19 real-time RT-PCR Kit)
02 • CE-IVD (PaxView ® HPV20 Genotyping MPCR-ULFA Kit)
09 • Minister award given by Ministry of SMZs and Startups(MSS)
2019
07 • KGMP and Manufacturing License(Relocation Approval)
• Acquire INNOBIZ Certificate
2018 11 • CE-IVD (PaxView TB, HPV16/18 MPCR-ULFA Kit)
®
12 • Acquire Certificate of KGMP
2017
• CE-IVD (PaxView TB/NTM, HPV16/18/Others MPCR-ULFA Kit)
®
11
• Acquire Certificate ISO13485
04 • Acquire MFDS Certificate of medical device manufacture
2016
03 • Registered as a Bio-Venture Company (KOTEC)
08 • Acquire approval of R&D Center (KOITA 2015113870)
2015
05 • Established PaxGenBio Co., Ltd.
